Document ID: chunk:federal_register_of_legislation:F2017L01637:body:0:p3
Version: federal_register_of_legislation:F2017L01637
Segment Type: other
Provision Reference: 
Character Range: 7912–9730

which it was granted as specified in the relevant notice of approval, the date on which the approval lapsed, and the reason for such lapsing in accordance with paragraph 19A(8)(b) and subsection 19A(9) of the Act
  9                                       medicine shortages information                                                                              a hyperlink to information relating to the active ingredient described in column 3 of item 1 that is publicly available, by reason other than this specification, on the Medicine Shortages Information Initiative database on the Therapeutic Goods Administration website; or, in the event that there is no such information, confirmation that no information is publicly available on the Medicines Shortages Information Initiative database in relation to that ingredient
  10                                      supply information                                                                                          information relating to the availability of the specified therapeutic goods during the period of approval under section 19A of the Act
  11                                      pharmaceutical benefits scheme information                                                                  a hyperlink to information relating to the specified therapeutic goods, that is publicly available, by reason other than this specification, on the Pharmaceutical Benefits Scheme website; or, in the event that there is no such information, confirmation that no information is publicly available on the Pharmaceutical Benefits Scheme website in relation to those goods

Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislation kept under the Legislation Act 2003. See http://www.legislation.gov.au.